Findings published in NEJM show that microarray finds significantly more clinically relevant information than current method Second study in NEJM shows significant advantages of microarray for ...
Expert Rev Mol Diagn. 2013;13(6):601-611. In other situations, normal microarray analysis in the presence of an abnormal karyotype, such as marker chromosomes, is reassuring, as it indicates that the ...
A new method for detecting abnormalities in unborn children is providing physicians with more information to analyze the results than conventional, microscopic testing. A new method for detecting ...
A clinical study of 4,400 women undergoing prenatal diagnosis showed that testing with chromosomal microarray analysis detected additional chromosomal deletions and duplications not detected by ...
A new method for detecting abnormalities in unborn children is providing physicians with more information to analyze the results than conventional, microscopic testing, according to two George ...
Fetal Well-Being Generally Fine After Strenuous Exercise Women do not necessarily consider the potential significance and ambiguity of the information they could receive from prenatal microarray ...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today introduced three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and postnatal ...
Genomic microarrays can detect copy-number variants not detectable by conventional cytogenetics. This technology is diffusing rapidly into prenatal settings even though the clinical implications of ...
To evaluate the clinical utility of chromosomal microarrays for prenatal diagnosis by a prospective study of fetuses with abnormalities detected on ultrasound. Patients referred for prenatal diagnosis ...
CombiMatrix, a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, today announced that it has entered into a strategic partnership with the ...
A large, multi-center clinical trial led by researchers from Columbia University Medical Center (CUMC) shows that a new genetic test resulted in significantly more clinically relevant information than ...
JA Rosenfeld is an employee of Signature Genomic Laboratories, a subsidiary of PerkinElmer, Inc. The authors have no other relevant affiliations or financial involvement with any organization or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results